Corrigendum to: 2269. HIV-Positive Individuals Who Report Being in Care Are Less Likely to Be Co-Infected With an STI; an Analysis of “Network Testing,” A Service Program Offering HIV and STI Testing Services to Individual at Risk for HIV

Australian guidelines for sexual history taking and sexually transmissible infection (STI) screening of HIV-positive patients do not exist. An audit was conducted to assess current practices of sexual history taking and STI testing of HIV-positive patients attending Hunter New England Sexual Health Unit.

Download Full-text

PrEP Continuation, HIV and STI Testing Rates, and Delivery of Preventive Care in a Clinic-Based Cohort

AIDS Education and Prevention ◽

10.1521/aeap.2018.30.5.393 ◽

2018 ◽

Vol 30 (5) ◽

pp. 393-405 ◽

Cited By ~ 10

Author(s):

Matthew A. Hevey ◽

Jennifer L. Walsh ◽

Andrew E. Petroll

Keyword(s):

Clinical Trials ◽

Preventive Care ◽

Retention In Care ◽

Clinical Settings ◽

Hiv Incidence ◽

Sti Testing ◽

Hiv And Sti Testing ◽

Study Completion ◽

Exposure Prophylaxis

HIV pre-exposure prophylaxis (PrEP) has been demonstrated to be a safe and effective method of reducing HIV incidence. Questions remain regarding PrEP's efficacy and outcomes in real-world clinical settings. We conducted a retrospective review to assess PrEP outcomes in an academic clinic setting and focused on retention in care, reasons for discontinuation, and receipt of appropriate preventive care (immunizations, HIV testing, and STI testing). One hundred thirty-four patients were seen between 2010 and 2016 over 309 visits. One hundred sixteen patients (87%) started daily PrEP and of those, 88 (76%) attended at least one 6-month follow-up visit. Over 60% of PrEP patients completed all recommended STI screening after starting PrEP. Only 40% of patients had all appropriate immunizations at baseline; 78% had all appropriate immunizations at study completion. This study demonstrated high rates of both retention and of attaining recommended preventive care in a clinical setting outside of the rigors of clinical trials.

Download Full-text

COVID-19 Infection in An HIV-Positive Patient

European Journal of Clinical Medicine ◽

10.24018/clinicmed.2021.2.1.14 ◽

2021 ◽

Vol 2 (1) ◽

pp. 13-14

Author(s):

Hulya Caskurlu ◽

Yasemin Cag

Keyword(s):

Immune Deficiency ◽

At Risk ◽

Lung Disease ◽

Chronic Lung Disease ◽

Age Groups ◽

Positive Patient ◽

Hiv Positive ◽

Hiv Patients ◽

Access To Treatment ◽

Continuous Access

The COVID-19 pandemic affects all age groups but follows a more mortal trajectory in patients with preexisting conditions such as immune deficiency, chronic lung disease, diabetes, and cardiovascular problems. Hence, HIV-positive patients with immune deficiency are at risk, therefore, these patients need to have continuous access to treatment during the pandemic. The number of defined COVID-19 positive HIV patients is very limited even though there are approximately 37.9 million HIV-positive patients globally. Therefore, we decided to publish this study reporting an HIV patient treated for COVID-19 in our clinic.

Download Full-text

HIV and STI prevalence and testing history among men who have sex with men in Hanoi, Vietnam

International Journal of STD & AIDS ◽

10.1177/09564624211060185 ◽

2021 ◽

pp. 095646242110601

Author(s):

Jane S Chen ◽

Sara N Levintow ◽

Ha V Tran ◽

Teerada Sripaipan ◽

Minh X Nguyen ◽

...

Keyword(s):

Social Stigma ◽

Prevalence Odds Ratio ◽

Cross Sectional ◽

Sexually Transmitted ◽

Healthcare Settings ◽

Sti Testing ◽

Hiv And Sti Testing ◽

Sex With Men ◽

Simplex Virus ◽

Herpes Simplex Virus 2

Background HIV and other sexually transmitted infections (STIs) have disproportionately affected communities of men who have sex with men (MSM). We describe HIV and STI prevalence and testing patterns among urban Vietnamese MSM. Methods We conducted a cross-sectional community-based study of MSM in Hanoi, Vietnam in 2016. Participants self-reported experiences of social stigma in healthcare settings and previous HIV and STI testing. STI testing included HIV, herpes simplex virus-2 (HSV-2), syphilis, gonorrhea, and chlamydia. Results 205 MSM participated in the study. STI prevalence was HIV (10%), HSV-2 (4%), syphilis (13%), gonorrhea (34%), and chlamydia (19%). More than half (55%) of participants tested positive for at least one STI. Most participants had been previously tested for HIV or another STI (72%), with 24% previously receiving a positive result. Perceived and enacted social stigma in healthcare contexts was negatively associated with previous HIV or STI testing (adjusted prevalence odds ratio (aPOR): 0.22; 95% confidence interval (CI): 0.10–0.48). Discussion High prevalence of STIs was observed among Vietnamese MSM, and perceived and enacted stigma was related to HIV and STI testing. Our findings reaffirm the importance of regular STI screening among this population as well as additional outreach to promote safe HIV and STI healthcare engagement.

Download Full-text

Vulnerabilities

Pandemics, Publics, and Narrative ◽

10.1093/oso/9780190683764.003.0006 ◽

2020 ◽

pp. 119-145

Author(s):

Mark Davis ◽

Davina Lohm

Keyword(s):

At Risk ◽

Health Status ◽

Lived Experiences ◽

Social Impact ◽

Respiratory Illness ◽

Point Of View ◽

Hiv Positive ◽

Historical Events ◽

The Social ◽

Severe Respiratory Illness

Chapter 6 explores the narratives of people who, due to vulnerabilities associated with their health status, including severe respiratory illness and HIV-positive serostatus, and because of coincident pregnancy, had to respond to the pandemic to protect themselves and unborn children. This chapter, therefore, addresses the importance of biography for understanding the social impact of pandemics. It shows how pandemics as historical events intersect with biographies and, from the point of view of individuals, cannot be meaningfully separated. This temporal intersectionality of pandemics and lived experiences is particularly well illuminated by a narrative approach. A feature of this chapter, too, is a focus on invisibility, that is, the ways in which being at risk was invisible to the “healthy” majority.

Download Full-text

Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction “R3” Trial): protocol and study design

Trials ◽

10.1186/s13063-019-3436-y ◽

2019 ◽

Vol 20 (1) ◽

Author(s):

Muktar H. Aliyu ◽

Usman J. Wudil ◽

Donna J. Ingles ◽

Bryan E. Shepherd ◽

Wu Gong ◽

...

Keyword(s):

At Risk ◽

Kidney Disease ◽

Risk Reduction ◽

Study Design ◽

Hiv Positive ◽

Trial Protocol ◽

Optimal Management ◽

Hiv Positive Adults

Download Full-text

P281 Reaching out to MSM who fled for war and LGBT oppression for HIV and STI testing, HBV vaccination and counselling

10.1136/sextrans-2019-sti.406 ◽

2019 ◽

Author(s):

Wim Zuilhof ◽

Hanna Bos

Keyword(s):

Hbv Vaccination ◽

Sti Testing ◽

Hiv And Sti Testing

Download Full-text

Lower sexually transmissible infection prevalence among lifetime exclusive women who have sex with women compared with women who have sex with women and men

Sexual Health ◽

10.1071/sh14181 ◽

2014 ◽

Vol 11 (6) ◽

pp. 592

Author(s):

Christina A. Muzny ◽

Richa Kapil ◽

Erika L. Austin ◽

Edward W. Hook ◽

William M. Geisler

Keyword(s):

At Risk ◽

Healthcare Providers ◽

Infection Prevalence ◽

Matched Group ◽

Sti Testing ◽

History Of ◽

Study Questionnaire ◽

Sexually Transmissible Infection ◽

Transmissible Infection

Background Sexually transmissible infection (STI) history, prevalence and seroprevalence among lifetime exclusive women who have sex with women (WSW) and an age-matched group of women who have sex with women and men (WSWM) was evaluated. Methods: Participants completed a study questionnaire and had genital specimens and sera collected for STI testing. Results: Twenty-one lifetime exclusive WSW and 42 WSWM were included. WSWM were more likely to report a history of prior STIs and be seropositive for chlamydia and HSV-2. Prevalent STIs were less common among WSW. Conclusions: While lifetime exclusive WSW are at risk of contracting STIs, WSWM are disproportionally affected. Healthcare providers should consider routine STI screening among WSW.

Download Full-text